The diabetes mellitus metabolic check-up objectives met in the rural area of Ourense, Spain;Cumplimiento de los objetivos de control metabólico en diabetes mellitus en el medio rural de Ourense

Revista Espanola de Salud Publica

Volumn 80, Issue 1, 2006, Pages 67-75

  Grávalos, Gabriel J Díaz ^a,e   Fernández, Gerardo Palmeiro ^b   Górriz, Inmaculada Casado ^c   García, Margarita Arandia ^d   Izaguirre, M Maite Portuburu ^a   Fernández, Luis A Vázquez ^a  

^a Centro de Salud Cea   (Spain)

^b Centro de Salud O Barco   (Spain)

^c Centro de Salud Allariz   (Spain)

^d Centro de Salud Coles   (Spain)

^e DIF   (France)

Author keywords

Diabetes mellitus; Primary Health Care; Quality control; Rural Health

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HEALTH CARE; HEALTH CARE FACILITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; METABOLIC REGULATION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; RISK FACTOR; RURAL AREA; SPAIN; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; RURAL POPULATION;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PATIENT COMPLIANCE; PRIMARY HEALTH CARE; RISK FACTORS; RURAL POPULATION; SPAIN;

EID: 33646083444     PISSN: 11355727     EISSN: 11355727     Source Type: Journal    
DOI: 10.1590/s1135-57272006000100007     Document Type: Article

References (28)

1. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2004; 27 (Suppl 1):S5-10.
2. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2005; 28 (Suppl 1): S4-36.
3. Franch Nadal J, Goday Arno A, Mata Cases M. COMBO. Actualización 2004. Criterios y pautas de terapia combinada en la diabetes tipo 2. Av Diabetol 2004; 20: 77-112.
4. de la Calle H, Costa A, Díez-Espino J, Franch J, Goday A. Evaluación del cumplimiento de los objetivos de control metabólico de la diabetes mellitus tipo 2. Estudio TranSTAR. Med Clin (Barc) 2003; 120:446-50.
5. Benito López P, García Mayor R, Puig Domingo M, Mesa Manteca J, Pallardo Sánchez LF, Faure Nogueras E et al. Perfil de los pacientes con diabetes mellitus tipo 2, en la Atención Primaria española Rev Clin Esp 2004; 204:1-2.
6. Andrus MR, Kelley KW, Murphey LM, Herndon KC. A comparison of diabetes care in rural and urban medical clinics in Alabama. J Community Health 2004; 29:29-44.
7. Samann A, Kaiser J, Hunger-Dathe W, Schiel R, Muller UA. Population-based measurement of quality of diabetes care using HbA1c values in the state of Thuringia/Germany. Exp Clin Endocrinol Diabetes 2004; 112:531-7.
8. Gamm L, Hutchison L. Rural health priorities in America: where you stand depends on where you sit. J Rural Health. 2003; 19:209-13.
9. Coon P, Zulkowski K. Adherence to American Diabetes Association standards of care by rural health care providers. Diabetes Care 2002; 25:2224-9.
10. Schiel R, Hoffmann A, Muller UA. Behandlungsqualitat bei Patienten mit Diabetes mellitus in einem landlichen Gebiet Deutschlands. Ergebnisse einer Populationsuntersuchung. Die ZEUVIN-Studie. Med Klin (Munich) 1999; 94: 127-32.
11. Toth EL, Majumdar SR, Guirguis LM, Lewanczuk RZ, Lee TK, Jonhson JA. Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvement. Pharmacotherapy 2003; 23:659-65.
12. Jaboureck O, Mounier-Vehier C, Devos P, Lions C, Dequiedt P, Beregi JP et al. Différences entre recommandations de prise en charge et stratégie globale médicale dans l'hypertension artérielle avec désordres métaboliques en France en 1999. Étude Ohara. Arch Mal Cœur Vaiss 2001 ; 94 : 834-8.
13. Virgós M, Castro M, Martínez S, Vila A. ¿Hacemos caso del resultado de la hemoglobina glicosilada a la hora de tratar a nuestros pacientes diabéticos? Aten Primaria 2002; 30:157-62.
14. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291:335-42.
15. Kirk JK, Poirier JE, Mattox MG, Thomas PM, Michielutte R. Compliance with national guidelines in patients with diabetes in a family practice clinic. Pharmacotherapy 2002; 22: 1541-6.
16. Beaton SJ, Nag SS, Gunter MJ, Gleeson JM, Sajjan SS, Alexander CM. Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care 2004; 27:694-8.
17. Hippisley-Cox J, O'Hanlon S, Coupland C. Association of deprivation, ethnicity, and sex with quality indicators for diabetes: population based survey of 53000 patients in primary care. BMJ 2004; 329:1267-70.
18. Nilsson PM, Theobald H, Journath G, Fritz T. Gender differences in risk factor control and treatment profile in diabetes: a study in 229 swedish primary health care centres. Scand J Prim Health Care 2004; 22:27-31.
19. Mehler PS, Esler A, Estacio RO, McKenzie TD, Hiatt WR, Schrier RW. Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes. Am J Med 2003; 114:377-82.
20. McFarlane SI, Jacober SJ, Winer N, Kaur J, Castro JP, Wui MA et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002; 25:718-23.
21. Supina AL, Guirguis LM, Majumdar SR, Lewanczuk RZ, Lee TK, Toth EL, Johnson JA. Treatment gaps for hypertension management in rural Canadian patients with type 2 diabetes mellitus. Clin Ther 2004; 26: 598-606.
22. Chamontin B, Lang T, Vaisse B, Nicodeme R, Antoine MP, Lazorthes ML et al. Hypertension artérielle et facteurs de risque cardiovasculaires associés chez les diabétiques. À propos de l'enquête PHARE menée en médecine générale. Arch Mal Cœur 2001 ; 94 : 869-73.
23. Esmatjes E, Castell C, Franch J, Puigoriol E, Hernáez R. Consumo de ácido acetilsalicílico en pacientes con diabetes mellitus. Med Clin 2004; 122:96-8.
24. Klinke JA, Johnson JA, Guirguis LM, Toth EL, Lee TK, Lewanczuk RZ, Majumdar SR. Underuse of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada. Clin Ther 2004; 26: 439-46.
25. Harris SB, Stewart M, Brown JB, Wetmore S, Faulds C, Webster-Bogaert S et al. Type 2 diabetes in family practice. Room for improvement. Can Fam Physician 2003; 49: 778-5.
26. Chin MH, Auerbach SB, Cook S, Harrison JF, Koppert J, Jin L et al. Quality of diabetes care in community health centers. Am J Public Health 2000; 90:431-4.
27. Grant RW, Buse JB, Meigs JB for the University HealthSystem Consortium (UHC) Diabetes Bench-marking Project Team. Quality of diabetes care in U.S. academic medical centers. Diabetes Care 2005; 28:337-442.
28. Renders CM, Valk GD, Frense LV, Schellevis FG, van Eijk JT, van der Wal G. Long-term effectiveness of a quality improvement program for patients with type 2 diabetes in general practice. Diabetes Care 2001; 24:1365-70.